본문 바로가기
KERD
논문KCI 등재

Antibiotic Control Policies in South Korea, 2000-2013

2

조회

0

다운로드

6

인용

0

참고문헌

키워드

주제분류내과학

초록

Antibiotic stewardship is a key strategy for limiting antibiotic resistance. Over the last decade the South Korean government has implemented a series of healthcare policies directed to this end, consisting of legislative separation of drug prescribing and dispensing, antibiotic utilization reviews, healthcare quality assessment, and public reporting. As a result, the proportion of antibiotic prescriptions for acute upper respiratory tract infections in primary healthcare facilities decreased from 72.9% in 2002 to 42.7% in 2013. However, no significant decrease in antibiotic resistance occurred over the same period in clinically important bacteria such as Streptococcus pneumoniae. These government-driven policies played a pivotal role in improving antibiotic use for outpatients and surgical patients in South Korea. However, to achieve long-lasting successful outcomes, coordinated efforts and communications among the stakeholders, including physicians and medical societies, are needed.

Abstract

Antibiotic stewardship is a key strategy for limiting antibiotic resistance. Over the last decade the South Korean government has implemented a series of healthcare policies directed to this end, consisting of legislative separation of drug prescribing and dispensing, antibiotic utilization reviews, healthcare quality assessment, and public reporting. As a result, the proportion of antibiotic prescriptions for acute upper respiratory tract infections in primary healthcare facilities decreased from 72.9% in 2002 to 42.7% in 2013. However, no significant decrease in antibiotic resistance occurred over the same period in clinically important bacteria such as Streptococcus pneumoniae. These government-driven policies played a pivotal role in improving antibiotic use for outpatients and surgical patients in South Korea. However, to achieve long-lasting successful outcomes, coordinated efforts and communications among the stakeholders, including physicians and medical societies, are needed.

참고문헌 (60)

  1. "Antimicrobial resistance:global report on surveillance, 2014"[URL]
  2. Cosgrove SE, "The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs", Clin Infect Dis, 42(Suppl 2), pp.S82~S89 (2006)
  3. "World Health Day 2011. Combat drug resistance: no action today means no cure tomorrow"[URL]
  4. MacDougall C, "Antimicrobial stewardship programs in health care systems", Clin Microbiol Rev, 18, pp.638~656 (2005)
  5. Davey P, "Interventions to improve antibiotic prescribing practices for hospital inpatients", Cochrane Database Syst Rev, 4, pp.CD003543~ (2013)
  6. Huttner B, "Success stories of implementation of antimicrobial stewardship: a narrative review", Clin Microbiol Infect, 20, pp.954~962 (2014)
  7. Goossens H, "Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC)", Euro Surveill, 13, pp.19036~ (2008)
  8. Xiao Y, "Changes in Chinese policies to promote the rational use of antibiotics", PLoS Med, 10, pp.e1001556~ (2013)
  9. Sabuncu E, "Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007", PLoS Med, 6, pp.e1000084~ (2009)
  10. Chahwakilian P, "Impact of the French campaign to reduce inappropriate ambulatory antibiotic use on the prescription and consultation rates for respiratory tract infections", J Antimicrob Chemother, 66, pp.2872~2879 (2011)
  11. Park S, "Patterns of antibiotics utilization in some respiratory diseases in clinics", J Korean Soc Qual Assur Health Care, 5, pp.58~75 (1998)
  12. Mangione-Smith R, "Measuring the quality of antibiotic prescribing for upper respiratory infections and bronchitis in 5 US health plans", Arch Pediatr Adolesc Med, 159, pp.751~757 (2005)
  13. Murphy M, "Antibiotic prescribing in primary care, adherence to guidelines and unnecessary prescribing--an Irish perspective", BMC Fam Pract, 13, pp.43~ (2012)
  14. Panasiuk L, "Antibiotics in the treatment of upper respiratory tract infections in Poland. Is there any improvement?", J Clin Pharm Ther, 35, pp.665~669 (2010)
  15. Nadeem Ahmed M, "Antibiotic prescription pattern for viral respiratory illness in emergency room and ambulatory care settings", Clin Pediatr (Phila), 49, pp.542~547 (2010)
  16. Yun JM, "Effect of public disclosure on antibiotic prescription rate for upper respiratory tract infections", JAMA Intern Med, 175, pp.445~447 (2015)
  17. Kim ES, "Impact of a national hospital evaluation program using clinical performance indicators on the use of surgical antibiotic prophylaxis in Korea", Int J Infect Dis, 16, pp.e187~e192 (2012)
  18. Chun CB, "Republic of Korea: Health system review", Health System in Transition, 11, pp.1~184 (2009)
  19. Comprehensive quality report of National Health Insurance 2010, "Health Insurance Review and Assessment Service", Health Insurance Review and Assessment Service, ~ (2010)
  20. "Results of quality asessment of prescriptions in 2013"[URL]
  21. Drug use evaluation, "Lee EK", Korea Institute for Health and Social Affairs, ~ (2000)
  22. Kwon S, "Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing", Soc Sci Med, 57, pp.529~538 (2003)
  23. Kim HJ, "Lessons from Korea's pharmaceutical policy reform: the separation of medical institutions and pharmacies for outpatient care", Health Policy, 68, pp.267~275 (2004)
  24. Kang HY, "Consumer use of publicly released hospital performance information: assessment of the National Hospital Evaluation Program in Korea", Health Policy, 89, pp.174~183 (2009)
  25. "Results of quality asessment of prescriptions in 2012"[URL]
  26. "Report of drug utilization review in the latter half of 2013"[URL]
  27. Lee YS, "Private practitioners' antimicrobial prescription patterns for acute respiratory infections in children", J Korean Public Health Assoc, 17, pp.3~19 (1991)
  28. 김남순, "급성 상기도 질환에서 일차의료의사의 항생제 처방에 영향을 주는 요인", 예방의학회지, 38(1), pp.1~8 (2005), 대한예방의학회
  29. Kim DS, "Physician’s belief on antibiotic use in upper respiratory tract infections", HIRA Policy Trend, 5, pp.33~41 (2011)
  30. Cho HJ, "Comparison of prescription behaviors between practicing physicians and pharmacists by simulated patients with common cold", J Korean Acad Fam Med, 22, pp.1394~1399 (2001)
  31. Cho HJ, "Prescription behaviours of office-based doctors to standardized common cold patients in Korea", Pharmacoepidemiol Drug Saf, 11, pp.401~405 (2002)
  32. Cho HJ, "Discolored nasal discharge did not increase the antibiotic prescription rate for the common cold patients", Pharmacoepidemiol Drug Saf, 14, pp.139~141 (2005)
  33. 정형준, "1차 의료기관에서 코감기에 처방한 항균제", Infection and Chemotherapy, 39(3), pp.125~132 (2007), 대한감염학회
  34. Study on the relationship of antibiotic use and resistance, "Lee EK", Korea Food & Drug Administration, ~ (2002)
  35. Analysis and evaluation of antibiotic use, "Health Insurance Review and Assessment Service", Health Insurance Review and Assessment Service, ~ (2006)
  36. 이영숙, "Temporal decrease in overall antibiotic consumption accompanying antibiotic prescribing rate disclosure policy: evidence from analysis of national health insurance claims data in South Korea", Archives of Pharmacal Research, 37(10), pp.1295~1300 (2014), 대한약학회[DOI]
  37. "OECD Health Statistics 2014"[URL]
  38. "Outcome evaluation models for the quality assessment of medical services"[URL]
  39. Kim SH, "Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP)study", Antimicrob Agents Chemother, 56, pp.1418~1426 (2012)
  40. Hong SI, "Analysis of antimicrobial susceptibility patterns of various microorganisms isolated from Seoul National University Hospital: statistical analysis on various clinical isolates during resecent 4 years (1980-1983)", Korean J Clin Pathol, 4, pp.149~162 (1984)
  41. Lee SY, "Prevalence of penicillin-resistant Streptococcus pneumoniae and antimicrobial susceptibility of beta-hemolytic Streptococcus and Enterococcus", J Korean Soc Chemother, 4, pp.44~51 (1986)
  42. 이혁민, "2005∼2006년 국내 12개 병원에서 분리된 주요 세균의 항균제 내성률", Annals of Clinical Microbiology, 10(1), pp.59~69 (2007), 대한임상미생물학회
  43. Chong Y, "Capsular types and antimicrobial resistance of Streptococcus pneumoniae isolated in Korea", Eur J Clin Microbiol Infect Dis, 14, pp.528~531 (1995)
  44. Song JH, "Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian network for surveillance of resistant pathogens (ANSORP)study", Clin Infect Dis, 28, pp.1206~1211 (1999)
  45. Song JH, "Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)", J Antimicrob Chemother, 53, pp.457~463 (2004)
  46. Prevalence of serotype and multidrug resistance of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia, "Bae SM", Public Health Wkly, 573~578, pp.Public Health Wkly Rep 7 (2014)
  47. 이현주, "Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines", Korean Journal of Pediatrics, 57(2), pp.55~66 (2014), 대한소아과학회
  48. 송준영, "폐렴구균백신", 대한의사협회지, 57(9), pp.780~788 (2014), 대한의사협회[DOI]
  49. 송준영, "Outpatient-Based Pneumococcal Vaccine Campaign and Survey of Perceptions about Pneumococcal Vaccination in Patients and Doctors", Yonsei Medical Journal, 54(2), pp.469~475 (2013), 연세대학교의과대학[DOI]
  50. Huttner B, "Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries", Lancet Infect Dis, 10, pp.17~31 (2010)
  51. Fung CH, "Systematic review: the evidence that publishing patient care performance data improves quality of care", Ann Intern Med, 148, pp.111~123 (2008)
  52. Rhee C, "Regulatory mandates for sepsis care--reasons for caution", N Engl J Med, 370, pp.1673~1676 (2014)
  53. Haustein T, "Use of benchmarking and public reporting for infection control in four high-income countries", Lancet Infect Dis, 11, pp.471~481 (2011)
  54. Thompson PL, "Has UK guidance affected general practitioner antibiotic prescribing for otitis media in children?", J Public Health (Oxf), 30, pp.479~486 (2008)
  55. Study on total volume of systemic antibacterials used of human body (2008-2009), "Oh OH", KCDC, ~ (2010)
  56. Chow AW, "IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults", Clin Infect Dis, 54, pp.e72~e112 (2012)
  57. DeMuri GP, "Clinical practice. Acute bacterial sinusitis in children", N Engl J Med, 367, pp.1128~1134 (2012)
  58. Shulman ST, "Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America", Clin Infect Dis, 55, pp.1279~1282 (2012)
  59. Mölstad S, "Sustained reduction of antibiotic use and low bacterial resistance:10-year follow-up of the Swedish Strama programme", Lancet Infect Dis, 8, pp.125~132 (2008)

관련 논문AI추천

이 간행물의 다른 논문 (18건)